Overview
Melanotan 1 is the research name for afamelanotide, a synthetic analogue of alpha-melanocyte-stimulating hormone (alpha-MSH) with higher activity than the natural hormone. It enhances eumelanin production by agonistically binding the melanocortin-1 receptor (MC1R) (Polanska 2024). A licensed afamelanotide product is FDA-approved for adults with erythropoietic protoporphyria (Wu 2021). That status applies to the licensed product only. Stackpure supplies melanotan 1 for laboratory research only.
Mechanism
The main properties of afamelanotide relate to MC1R agonism and the resulting increase in eumelanin. Reviews also describe dual photoprotective and anti-inflammatory effects (Wu 2021, Polanska 2024).
| Finding | Model | Source |
|---|---|---|
| Synthetic alpha-MSH analogue; MC1R agonist; raises eumelanin | Review | Polanska 2024 |
| Used since 2016 for erythropoietic protoporphyria; improved light tolerance and pain-free sun time | Review of clinical studies | Polanska 2024 |
| RCT evidence beyond EPP in polymorphic light eruption and vitiligo | Review of trials | Wu 2021 |
| Diffuse hyperpigmentation in almost all patients; no serious adverse effects reported | Review | Wu 2021 |
Published dermatology literature
A review of the literature and registered trials found randomized trial evidence for afamelanotide in several conditions beyond erythropoietic protoporphyria, including polymorphic light eruption and vitiligo, with smaller studies in acne vulgaris, Hailey-Hailey disease and solar urticaria. Diffuse hyperpigmentation was experienced by almost all patients, and the authors state that larger studies are needed (Wu 2021).
What the sources do not show
- The sources checked are clinical reviews of the licensed product. They do not report data for research-grade vials, nasal sprays or pre-mixed formats.
- No source checked gives receptor binding constants or half-life figures.
- Comparisons with melanotan 2 are not covered here. See the melanotan 2 overview for that compound.
Related research products and tools
- Melanotan I peptide vial
- Melanotan I pre-mixed peptide
- Melanotan I nasal spray
- Peptide reconstitution calculator
- Melanotan 2 research overview
Frequently Asked Questions
What is melanotan 1?
The research name for afamelanotide, a synthetic alpha-MSH analogue (Polanska 2024).
Which receptor does it act on?
The melanocortin-1 receptor (MC1R), raising eumelanin production (Polanska 2024).
What is the most common effect reported?
Diffuse hyperpigmentation, experienced by almost all patients in the reviewed studies (Wu 2021).
Key References
- Wu J, et al. Afamelanotide: an orphan drug with potential for broad dermatologic applications. J Drugs Dermatol. 2021. PubMed 33683075
- Polanska A, et al. Afamelanotide in protoporphyria and other skin diseases: a review. Postepy Dermatol Alergol. 2024. PubMed 38784937
For research use only. Not for human consumption.